Table 2 Clinical findings of the patients treated for acute cholecystitis during the COVID-19 pandemic comparing those who survived (n = 2482) and those who died (n = 64)
Variable | Alive, n = 2482 | Dead, n = 64 | p |
|---|---|---|---|
Abdominal findings | < 0.001 | ||
No pain | 53 (2.1%) | 1 (1.6%) | |
Localized pain | 1545 (62.5%) | 23 (35.9%) | |
Localized pain and rigidity | 568 (23%) | 12 (18.8%) | |
Diffuse abdominal pain | 307 (12.4%) | 28 (43.8%) | |
Radiological assessment (US/CT) | 1653/2469 (66% US) | 25/64 (39% US | < 0.001 |
816/2469 (33% CT) | 39/64 (60% CT) | ||
Core temperature (°C) | 37.16 (4.55) | 37.31 (0.98) | < 0.001 |
Heart rate (bpm) | 84.9 (27.5) | 94.8 (19.2) | < 0.001 |
Systolic blood pressure (mmHg) | 131.4 (23.1) | 115.4 (31.2) | < 0.001 |
Respiratory rate (breaths/min) | 17.4 (4.9) | 20.6 (4.4) | < 0.001 |
SpO2 (%) | 94.5 (13.8) | 92.8 (5.6) | < 0.001 |
Acalcular cholecystitis | 94/2465 (3.8%) | 4/63 (6.3%) | |
Severity of acute cholecystitis | < 0.001 | ||
Mild | 1141 (47.9%) | 4 (6.7%) | |
Moderate | 1008 (42.3%) | 22 (36.7%) | |
Severe | 233 (9.8%) | 34 (56.7%) | |
Gallbladder wall thickness (mm) | 5.4 (SD 3.4) | 6.24 (SD 2.5) | < 0.001 |